5-Amino-1MQ 5mg

Introduction

5-Amino-1MQ (5-Amino-1-methylquinolinium) is a selective, membrane-permeable small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that has emerged as a critical regulator of energy metabolism, adipocyte biology, and NAD⁺ homeostasis. Originally developed through structure-activity relationship optimization by Neelakantan and colleagues, 5-Amino-1MQ demonstrates high-affinity NNMT inhibition with an IC₅₀ in the low nanomolar range and excellent cell permeability characteristics. By blocking NNMT activity, 5-Amino-1MQ prevents the methylation and subsequent degradation of nicotinamide, thereby preserving cellular NAD⁺ pools and modulating downstream metabolic signaling cascades. Research spanning from landmark studies in Nature to recent investigations in muscle biology has positioned 5-Amino-1MQ as a compelling tool compound for investigating metabolic disorders, obesity, sarcopenia, and the fundamental biology of NAD⁺-dependent processes.

Molecular Background

NNMT: A Metabolic Gatekeeper

Nicotinamide N-methyltransferase (NNMT) catalyzes the transfer of a methyl group from S-adenosyl methionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA) and S-adenosyl homocysteine (SAH). This reaction represents a dominant clearance pathway for nicotinamide, directly competing with the NAD⁺ salvage pathway wherein nicotinamide is instead recycled to NAD⁺ via nicotinamide phosphoribosyltransferase (NAMPT). When NNMT activity is elevated, nicotinamide is preferentially directed toward methylation and excretion rather than NAD⁺ biosynthesis, resulting in a functional NAD⁺ deficit at the cellular level.

Mehranism of Inhibition by 5-Amino-1MQ

5-Amino-1MQ functions as a competitive substrate analog that occupies the nicotinamide binding pocket of NNMT with high affinity. The quinolinium core of 5-Amino-1MQ mimics the N-methylated pyridinium moiety of the transition state, while the 5-amino substituent establishes additional hydrogen-bonding interactions within the active site. Structure-activity relationship studies have demonstrated that the 5-amino substitution is critical for achieving nanomolar potency, distinguishing 5-Amino-1MQ from earlier NNMT inhibitors bearing different substitution patterns. The methylquinolinium scaffold confers permanent positive charge character, which contributes to selective NNMT binding while maintaining sufficient lipophilicity for passive membrane permeability. By inhibiting NNMT, 5-Amino-1MQ reduces consumption of both nicotinamide and methyl donors, shifting cellular metabolism toward NAD⁺ biosynthesis and altering the methylation landscape.

Research Applications

Obesity and Metabolic Disorders

The seminal finding that NNMT knockdown protects against diet-induced obesity, published by Kraus and colleagues in Nature, established NNMT as a novel regulator of whole-body energy expenditure. Adipose tissue NNMT expression is markedly elevated in obese mice and humans, and its genetic silencing increases NAD⁺ levels, SIRT1 activity, and energy expenditure through enhanced adipose tissue lipolysis and thermogenesis. Building on this foundation, Neelakantan and colleagues demonstrated that pharmacological NNMT inhibition with 5-Amino-1MQ reverses high-fat diet-induced obesity in mice, reducing body weight and adiposity without affecting food intake. The anti-obesity effects are attributed to increased cellular NAD⁺ content, activation of SIRT1-dependent signaling, and upregulation of genes involved in fatty acid oxidation and mitochondrial biogenesis in white adipose tissue. More recent studies combining NNMT inhibition with caloric restriction revealed synergistic effects on the gut microbiome composition, suggesting multi-system metabolic benefits.

Sarcopenia and Skeletal Muscle Aging

A particularly promising application of 5-Amino-1MQ has emerged in the context of skeletal muscle aging. NNMT expression increases progressively in aged skeletal muscle, and NNMT inhibition with 5-Amino-1MQ has been shown to activate senescent muscle stem cells (satellite cells) and improve the regenerative capacity of aged skeletal muscle. In aged mice, NNMT inhibition mimics and amplifies exercise-mediated improvements in muscle function, enhancing grip strength and exercise endurance. Mechanistically, NNMT inhibition in aged muscle restores NAD⁺ levels, improves mitochondrial function, and reduces markers of cellular senescence, positioning 5-Amino-1MQ as a candidate for investigating sarcopenia interventions and muscle regenerative biology.

Adipocyte Biology and Adipogenesis

NNMT plays a dynamic role during adipocyte differentiation. Research by Roberti and colleagues has elucidated that NNMT regulates the glucocorticoid signaling pathway during the early phase of adipogenesis, with NNMT expression peaking transiently and then declining as differentiation proceeds. Pharmacological inhibition with 5-Amino-1MQ during specific phases of adipogenesis modulates glucocorticoid receptor signaling and alters the adipogenic transcriptional program. These findings have broader implications for understanding adipose tissue expandability, adipocyte hypertrophy versus hyperplasia, and the development of metabolically healthy versus dysfunctional adipose tissue in obesity.

NAD⁺ Biology and Cellular Energetics

The intersection of NNMT inhibition and NAD⁺ metabolism represents a fundamental axis of 5-Amino-1MQ research. By preventing the NNMT-mediated drain on nicotinamide, 5-Amino-1MQ increases substrate availability for NAD⁺ synthesis through the salvage pathway. Elevated NAD⁺ in turn activates sirtuin deacetylases (particularly SIRT1 and SIRT3), supports PARP-mediated DNA repair, and enhances mitochondrial oxidative phosphorylation. The NAD⁺-boosting effect of 5-Amino-1MQ is mechanistically distinct from NAD⁺ precursor supplementation (such as nicotinamide riboside or nicotinamide mononucleotide), as it operates by reducing NAD⁺ consumption rather than by providing additional precursor. This “plug the drain” approach may offer complementary or synergistic benefits when investigated alongside direct NAD⁺ precursor strategies.

Comparative Context

5-Amino-1MQ belongs to a class of small molecule NNMT inhibitors that includes compounds such as JBSNF-000088 and related methylquinolinium analogs. Among these, 5-Amino-1MQ distinguishes itself through its optimized potency (low nanomolar IC₅₀), well-characterized oral bioavailability in rodent models, and demonstrated membrane permeability that enables intracellular target engagement. Unlike genetic approaches such as NNMT knockdown or knockout, pharmacological inhibition with 5-Amino-1MQ provides temporal control and reversibility suitable for ex vivo and in vivo experimental paradigms. Relative to NAD⁺ precursor compounds, 5-Amino-1MQ targets the enzymatic depletion of NAD⁺ precursors rather than flooding the system with exogenous substrate, representing a mechanistically orthogonal approach to modulating NAD⁺ homeostasis.

Safety & Handling

5-Amino-1MQ is supplied as a research compound intended exclusively for laboratory and scientific investigation purposes. It is not intended for human consumption, therapeutic use, or diagnostic applications. Standard laboratory safety practices should be observed during handling, including the use of appropriate personal protective equipment (gloves, lab coat, and eye protection). The compound should be stored at -20°C, protected from light and moisture, and dissolved in appropriate solvents (typically DMSO or aqueous buffers) immediately prior to experimental use. Researchers should consult the provided certificate of analysis for batch-specific purity data, solubility information, and storage recommendations. All experimental protocols involving 5-Amino-1MQ should be conducted in compliance with institutional biosafety guidelines and applicable regulatory requirements governing research chemical use.

References

1. Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262. PMID: 24717514
2. Neelakantan H, Vance V, Wang HL, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018;147:141-152. PMID: 29155147
3. Neelakantan H, Brightwell CR, Graber TG, et al. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochem Pharmacol. 2019;163:481-493. PMID: 30753815
4. Dimet-Wiley A, Wu Q, Wiley JT, et al. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice. Sci Rep. 2022;12(1):484. PMID: 35013352
5. Roberti A, Tejedor JR, Diaz-Moreno I, et al. Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis. Sci Rep. 2023;13(1):8293. PMID: 37217546
6. Dimet-Wiley AL, Latham CM, Brightwell CR, et al. Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice. Sci Rep. 2024;14(1):15554. PMID: 38969654